Feature Channels: Substance Abuse

• share
• favorite_border

The Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced an investment of $6.5 million over five years for six projects funded through the Canadian Institutes of Health Research (CIHR) Mental Health in the Early Years (MHITEY) initiative. MHITEY, led by the CIHR’s Institute of Human Development, Child and Youth Health, will help to advance Canada’s mental health strategy by identifying solutions for safe and equitable programs and services for diverse populations, and through adopting, adapting and improving the use of evidence-based practices in clinical, community, and public health settings.

• share
• favorite_border

Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive. Now scientists at Washington University School of Medicine have identified a potential pathway to pain relief that neither triggers addiction nor causes hallucinations.

• share
• favorite_border

A new study found a declining proportion of DATA-waivered clinicians prescribed any buprenorphine between 2017 and 2021. While the number of waivered clinicians increased significantly during the five-year window, only one out of three prescribed any buprenorphine as of May 2021. Furthermore, the majority of prescriptions were written by clinicians who specialize in treating opioid use disorder. The new study was published as a research letter in JAMA.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

One in five adults in California, or an estimated 6.5 million people, are concerned that someone they know, usually a friend or family member, is at risk of harming themselves or others, according to new research published in Preventive Medicine. Alcohol and substance misuse, a history of violence, and firearm access were common reasons for concerns about potential violence.

• share
• favorite_border

Treating opioid addiction should be much easier now than it was a few years ago, thanks to pandemic-era rule changes that aim to improve access to buprenorphine, a medicine proven to help in recovery. But a new study shows prescriptions and adherence rates have remained flat.

• share
• favorite_border

UCLA Health investigators are leading a new, six-city trial of injectable buprenorphine for treatment of methamphetamine use disorder in adults who also use opioids.

• share
• favorite_border

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

• share
• favorite_border

Opioids are commonly prescribed as an all-purpose pain killer for patients with the condition

• share
• favorite_border

A study, led by University of Oregon neuroscientist Shawn Lockery, points to worms as a useful tool for understanding more about the many roles that cannabinoids naturally play in the body. And it could help researchers develop better drugs that target this system.

• share
• favorite_border

About one in five cases of child abuse and neglect is committed by both mothers and fathers, but nearly all the research attention has been focused on when just one parent is involved. A new study that aimed to shine a light on risk factors for mistreatment coming from both parents found some surprising results.